Treating Pain Effectively - New Study Results Confirm Improved Gastrointestinal Tolerability Of Tapentadol

Results from two phase III clinical studies of tapentadol immediate release tablets (IR) suggest a significantly improved gastrointestinal tolerability(1) as well as safety(2) profile compared to oxycodone HCl IR. The data were presented by the German pharmaceutical company Grunenthal at this year’s Annual Congress of the European League against Rheumatism (EULAR, June 11-14, Paris, France).

More: continued here

Filed under: Pain / Anesthetics on June 19th, 2008